| ■ 영문 제목 : Global Vaccines Administered Orally Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02209 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 119 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 구강 투여 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (사람, 동물)와 용도별 시장규모 (공공용, 개인용) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 구강 투여 백신 시장 점유율 - 지역별 구강 투여 백신 시장규모 - 주요지역의 종류별 시장규모 (사람, 동물) - 주요지역의 용도별 시장규모 (공공용, 개인용) - 미주의 구강 투여 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 구강 투여 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 구강 투여 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 구강 투여 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 구강 투여 백신 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Vaccines Administered Orally will have significant change from previous year. By the most conservative estimates of global Vaccines Administered Orally market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vaccines Administered Orally market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines Administered Orally market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Human
Animal
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Public
Private
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1 Scope of the Report 2 Executive Summary 3 Global Vaccines Administered Orally by Company 4 Vaccines Administered Orally by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Vaccines Administered Orally Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Vaccines Administered Orally Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Human Table 3. Major Players of Animal Table 4. Global Vaccines Administered Orally Sales by Type (2016-2021) & (K Units) Table 5. Global Vaccines Administered Orally Sales Market Share by Type (2016-2021) Table 6. Global Vaccines Administered Orally Revenue by Type (2016-2021) & ($ million) Table 7. Global Vaccines Administered Orally Revenue Market Share by Type (2016-2021) Table 8. Global Vaccines Administered Orally Sale Price by Type (2016-2021) Table 9. Global Vaccines Administered Orally Sales by Application (2016-2021) & (K Units) Table 10. Global Vaccines Administered Orally Sales Market Share by Application (2016-2021) Table 11. Global Vaccines Administered Orally Value by Application (2016-2021) Table 12. Global Vaccines Administered Orally Revenue Market Share by Application (2016-2021) Table 13. Global Vaccines Administered Orally Sale Price by Application (2016-2021) Table 14. Global Vaccines Administered Orally Sales by Company (2019-2021) & (K Units) Table 15. Global Vaccines Administered Orally Sales Market Share by Company (2019-2021) Table 16. Global Vaccines Administered Orally Revenue by Company (2019-2021) ($ Millions) Table 17. Global Vaccines Administered Orally Revenue Market Share by Company (2019-2021) Table 18. Global Vaccines Administered Orally Sale Price by Company (2019-2021) Table 19. Key Manufacturers Vaccines Administered Orally Producing Area Distribution and Sales Area Table 20. Players Vaccines Administered Orally Products Offered Table 21. Vaccines Administered Orally Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Vaccines Administered Orally Sales by Region (2016-2021) (K Units) Table 25. Global Vaccines Administered Orally Sales Market Share by Region (2016-2021) Table 26. Global Vaccines Administered Orally Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Vaccines Administered Orally Revenue Market Share by Region (2016-2021) Table 28. Americas Vaccines Administered Orally Sales by Country (2016-2021) & (K Units) Table 29. Americas Vaccines Administered Orally Sales Market Share by Country (2016-2021) Table 30. Americas Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Vaccines Administered Orally Revenue Market Share by Country (2016-2021) Table 32. Americas Vaccines Administered Orally Sales by Type (2016-2021) & (K Units) Table 33. Americas Vaccines Administered Orally Sales Market Share by Type (2016-2021) Table 34. Americas Vaccines Administered Orally Sales by Application (2016-2021) & (K Units) Table 35. Americas Vaccines Administered Orally Sales Market Share by Application (2016-2021) Table 36. APAC Vaccines Administered Orally Sales by Region (2016-2021) & (K Units) Table 37. APAC Vaccines Administered Orally Sales Market Share by Region (2016-2021) Table 38. APAC Vaccines Administered Orally Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Vaccines Administered Orally Revenue Market Share by Region (2016-2021) Table 40. APAC Vaccines Administered Orally Sales by Type (2016-2021) & (K Units) Table 41. APAC Vaccines Administered Orally Sales Market Share by Type (2016-2021) Table 42. APAC Vaccines Administered Orally Sales by Application (2016-2021) & (K Units) Table 43. APAC Vaccines Administered Orally Sales Market Share by Application (2016-2021) Table 44. Europe Vaccines Administered Orally Sales by Country (2016-2021) & (K Units) Table 45. Europe Vaccines Administered Orally Sales Market Share by Country (2016-2021) Table 46. Europe Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Vaccines Administered Orally Revenue Market Share by Country (2016-2021) Table 48. Europe Vaccines Administered Orally Sales by Type (2016-2021) & (K Units) Table 49. Europe Vaccines Administered Orally Sales Market Share by Type (2016-2021) Table 50. Europe Vaccines Administered Orally Sales by Application (2016-2021) & (K Units) Table 51. Europe Vaccines Administered Orally Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Vaccines Administered Orally Sales by Country (2016-2021) & (K Units) Table 53. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Vaccines Administered Orally Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Vaccines Administered Orally Sales by Type (2016-2021) & (K Units) Table 57. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Vaccines Administered Orally Sales by Application (2016-2021) & (K Units) Table 59. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Vaccines Administered Orally Table 61. Key Application and Potential Industries of Vaccines Administered Orally Table 62. Key Challenges of Vaccines Administered Orally Table 63. Key Trends of Vaccines Administered Orally Table 64. Vaccines Administered Orally Distributors List Table 65. Vaccines Administered Orally Customer List Table 66. Global Vaccines Administered Orally Sales Forecast by Region (2021-2026) & (K Units) Table 67. Global Vaccines Administered Orally Consumption Market Forecast by Region Table 68. Global Vaccines Administered Orally Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Vaccines Administered Orally Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units) Table 71. Americas Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Vaccines Administered Orally Sales Forecast by Region (2021-2026) & (K Units) Table 73. APAC Vaccines Administered Orally Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units) Table 75. Europe Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Vaccines Administered Orally Sales Forecast by Country (2021-2026) & (K Units) Table 77. Middle East & Africa Vaccines Administered Orally Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Vaccines Administered Orally Sales Forecast by Type (2021-2026) & (K Units) Table 79. Global Vaccines Administered Orally Sales Market Share Forecast by Type (2021-2026) Table 80. Global Vaccines Administered Orally Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Vaccines Administered Orally Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Vaccines Administered Orally Sales Forecast by Application (2021-2026) & (K Units) Table 83. Global Vaccines Administered Orally Sales Market Share Forecast by Application (2021-2026) Table 84. Global Vaccines Administered Orally Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Vaccines Administered Orally Revenue Market Share Forecast by Application (2021-2026) Table 86. Merck Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 87. Merck Vaccines Administered Orally Product Offered Table 88. Merck Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 89. Merck Main Business Table 90. Merck Latest Developments Table 91. GSK Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 92. GSK Vaccines Administered Orally Product Offered Table 93. GSK Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 94. GSK Main Business Table 95. GSK Latest Developments Table 96. Sanofi Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 97. Sanofi Vaccines Administered Orally Product Offered Table 98. Sanofi Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 99. Sanofi Main Business Table 100. Sanofi Latest Developments Table 101. Lanzhou Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 102. Lanzhou Institute Vaccines Administered Orally Product Offered Table 103. Lanzhou Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 104. Lanzhou Institute Main Business Table 105. Lanzhou Institute Latest Developments Table 106. Serum Institute Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 107. Serum Institute Vaccines Administered Orally Product Offered Table 108. Serum Institute Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 109. Serum Institute Main Business Table 110. Serum Institute Latest Developments Table 111. Valneva Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 112. Valneva Vaccines Administered Orally Product Offered Table 113. Valneva Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 114. Valneva Main Business Table 115. Valneva Latest Developments Table 116. Shanghai United Cell Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 117. Shanghai United Cell Vaccines Administered Orally Product Offered Table 118. Shanghai United Cell Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 119. Shanghai United Cell Main Business Table 120. Shanghai United Cell Latest Developments Table 121. Bibcol Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 122. Bibcol Vaccines Administered Orally Product Offered Table 123. Bibcol Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 124. Bibcol Main Business Table 125. Bibcol Latest Developments Table 126. PaxVax Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 127. PaxVax Vaccines Administered Orally Product Offered Table 128. PaxVax Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 129. PaxVax Main Business Table 130. PaxVax Latest Developments Table 131. Vabiotech Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 132. Vabiotech Vaccines Administered Orally Product Offered Table 133. Vabiotech Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 134. Vabiotech Main Business Table 135. Vabiotech Latest Developments Table 136. Tiantan Biological Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 137. Tiantan Biological Vaccines Administered Orally Product Offered Table 138. Tiantan Biological Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 139. Tiantan Biological Main Business Table 140. Tiantan Biological Latest Developments Table 141. EuBiologics Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 142. EuBiologics Vaccines Administered Orally Product Offered Table 143. EuBiologics Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 144. EuBiologics Main Business Table 145. EuBiologics Latest Developments Table 146. Panacea Biotec Ltd Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 147. Panacea Biotec Ltd Vaccines Administered Orally Product Offered Table 148. Panacea Biotec Ltd Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 149. Panacea Biotec Ltd Main Business Table 150. Panacea Biotec Ltd Latest Developments Table 151. Bio-Med Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 152. Bio-Med Vaccines Administered Orally Product Offered Table 153. Bio-Med Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 154. Bio-Med Main Business Table 155. Bio-Med Latest Developments Table 156. Halfkin Bio-Pharmaceuticals Basic Information, Vaccines Administered Orally Manufacturing Base, Sales Area and Its Competitors Table 157. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Offered Table 158. Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 159. Halfkin Bio-Pharmaceuticals Main Business Table 160. Halfkin Bio-Pharmaceuticals Latest Developments List of Figures Figure 1. Picture of Vaccines Administered Orally Figure 2. Vaccines Administered Orally Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Vaccines Administered Orally Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Vaccines Administered Orally Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Vaccines Administered Orally Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Human Figure 10. Product Picture of Animal Figure 11. Global Vaccines Administered Orally Sales Market Share by Type in 2020 Figure 12. Global Vaccines Administered Orally Revenue Market Share by Type (2016-2021) Figure 13. Vaccines Administered Orally Consumed in Public Figure 14. Global Vaccines Administered Orally Market: Public (2016-2021) & (K Units) Figure 15. Vaccines Administered Orally Consumed in Private Figure 16. Global Vaccines Administered Orally Market: Private (2016-2021) & (K Units) Figure 17. Global Vaccines Administered Orally Sales Market Share by Application (2016-2021) Figure 18. Global Vaccines Administered Orally Revenue Market Share by Application in 2020 Figure 19. Vaccines Administered Orally Revenue Market by Company in 2020 ($ Million) Figure 20. Global Vaccines Administered Orally Revenue Market Share by Company in 2020 Figure 21. Global Vaccines Administered Orally Sales Market Share by Regions (2016-2021) Figure 22. Global Vaccines Administered Orally Revenue Market Share by Region in 2020 Figure 23. Americas Vaccines Administered Orally Sales 2016-2021 (K Units) Figure 24. Americas Vaccines Administered Orally Revenue 2016-2021 ($ Millions) Figure 25. APAC Vaccines Administered Orally Sales 2016-2021 (K Units) Figure 26. APAC Vaccines Administered Orally Revenue 2016-2021 ($ Millions) Figure 27. Europe Vaccines Administered Orally Sales 2016-2021 (K Units) Figure 28. Europe Vaccines Administered Orally Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Vaccines Administered Orally Sales 2016-2021 (K Units) Figure 30. Middle East & Africa Vaccines Administered Orally Revenue 2016-2021 ($ Millions) Figure 31. Americas Vaccines Administered Orally Sales Market Share by Country in 2020 Figure 32. Americas Vaccines Administered Orally Revenue Market Share by Country in 2020 Figure 33. Americas Vaccines Administered Orally Sales Market Share by Type in 2020 Figure 34. Americas Vaccines Administered Orally Sales Market Share by Application in 2020 Figure 35. United States Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Vaccines Administered Orally Sales Market Share by Region in 2020 Figure 40. APAC Vaccines Administered Orally Revenue Market Share by Regions in 2020 Figure 41. APAC Vaccines Administered Orally Sales Market Share by Type in 2020 Figure 42. APAC Vaccines Administered Orally Sales Market Share by Application in 2020 Figure 43. China Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 47. India Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Vaccines Administered Orally Sales Market Share by Country in 2020 Figure 50. Europe Vaccines Administered Orally Revenue Market Share by Country in 2020 Figure 51. Europe Vaccines Administered Orally Sales Market Share by Type in 2020 Figure 52. Europe Vaccines Administered Orally Sales Market Share by Application in 2020 Figure 53. Germany Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 54. France Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Vaccines Administered Orally Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Vaccines Administered Orally Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Vaccines Administered Orally Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Vaccines Administered Orally Sales Market Share by Application in 2020 Figure 62. Egypt Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Vaccines Administered Orally Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 구강 투여 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02209) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 구강 투여 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |